Zealand Pharma A/S (CPH:ZEAL)

Instructure Holdings Revenue

Zealand Pharma had revenue of 8.09M DKK in the quarter ending March 31, 2025, a decrease of -46.37%. This brings the company's revenue in the last twelve months to 55.69M, down -83.82% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.

• Revenue (ttm): 55.69M
• Revenue Growth: -83.82%
• P/S Ratio: 425.58
• Revenue / Employee: 144.66K
• Employees: 335
• Market Cap: 23.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.69M	-280.10M	-81.71%
Dec 31, 2023	342.79M	238.80M	229.65%
Dec 31, 2022	103.99M	-4.56M	-4.20%
Dec 31, 2021	108.55M	-83.46M	-43.47%
Dec 31, 2020	192.00M	150.67M	364.52%